Keywords: اصلاح قصد درمان; AEs; adverse events; ITT; intention-to-treat; MedDRA; Medical Dictionary for Regulatory Activities; MITT; modified intention-to-treat; MPP; modified per-protocol; PP; per-protocol; PT; preferred term; SD; standard deviation; SOC; system organ class; Otomy
مقالات ISI اصلاح قصد درمان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اصلاح قصد درمان; AIHQ; Ambiguous Intentions Hostility Questionnaire; ER-40; Emotion Recognition-40 task; Eyes Test; Reading the Mind in the Eyes Test; GSS; Global social skill; IU; International Units; mITT; Modified intention-to-treat; NVSS; Nonverbal social skill; PANSS
Keywords: اصلاح قصد درمان; Deviation from intention-to-treat; Modified intention-to-treat; Bias; Epidemiology; Randomized trials; Meta-analysis;
Keywords: اصلاح قصد درمان; Omalizumab; Urticaria; Chronic spontaneous; Chronic idiopathic; Itch; Hive; Pruritus; Wheal; Antihistamine; AE; Adverse event; CI; Confidence interval; CIU; Chronic idiopathic urticaria; CSU; Chronic spontaneous urticaria; CU; Chronic urticaria; DLQI; Der
A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines
Keywords: اصلاح قصد درمان; ADR; Adverse Drug Reaction; AE; Adverse Event; CI; Confidence Interval; CV; Coefficient of Variation; GAVI; Gavi, The Vaccine Alliance; GMR; Geometric Mean Ratio; GMT; Geometric Mean Titer; GTFCC; Global Task Force for Cholera Control; IRB; Institutional
Impact of Direct Acting Antiviral Therapy for Treatment of Hepatitis C Genotypes 1, 3 and 4: A Real Life Experience from India
Keywords: اصلاح قصد درمان; DAA; Direct Acting Antiviral; DCV; Daclatasvir; EASL; European Association of Study of the Liver (EASL); ETR; End of Treatment Response; HBV; Hepatitis B; HCC; Hepatocellular Carcinoma; HCV; Hepatitis C Virus; HIV; Human Immunedeficiency Virus; ITT; inten
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Keywords: اصلاح قصد درمان; Combined Remission; Clinical Remission; Anal Fistula; Cell Therapy; CDAI; Crohn's Disease Activity Index; CI; confidence interval; Cx601; allogeneic; expanded; adipose-derived stem cells; IBDQ; inflammatory bowel disease questionnaire; LOCF; last observ
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial
Keywords: اصلاح قصد درمان; Alirocumab; Diabetes; Insulin; LDL-C; ODYSSEY; PCSK9; AE; adverse event; Apo; apolipoprotein; ASCVD; atherosclerotic cardiovascular disease; CHD; coronary heart disease; CV; cardiovascular; CVD; cardiovascular disease; DM; diabetes mellitus; HDL-C; high-d
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Keywords: اصلاح قصد درمان; antiplatelet therapy; bleeding; coronary artery disease; outcomes; CHAMPION; Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition; CI; confidence interval; GPI; glycoprotein IIb/IIIa inhibitor; GUSTO; Global Use of Strate
Outcomes With Cangrelor Versus Clopidogrel on a Background of Bivalirudin: Insights From the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI])
Keywords: اصلاح قصد درمان; bivalirudin; cangrelor; CHAMPION PHOENIX; stent thrombosis; CI; confidence interval; GUSTO; Global Use of Strategies to Open Occluded Arteries; IDR; ischemia-driven revascularization; MI; myocardial infarction; mITT; modified intention-to-treat; NSTE-ACS;
Research ArticleSwitching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
Keywords: اصلاح قصد درمان; ALT; alanine aminotransferase; CHB; chronic hepatitis B; CI; confidence interval; ETV; entecavir; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; ITT; intention-to-treat; mITT; modified intention-to-treat; NA; nuc
Combination of Vaniprevir With Peginterferon and Ribavirin Significantly Increases the Rate of SVR in Treatment-Experienced Patients With Chronic HCV Genotype 1 Infection and Cirrhosis
Keywords: اصلاح قصد درمان; Clinical Trial; Fibrosis; Direct-Acting Antiviral Agent; HCV; hepatitis C virus; LLQ; lower limit of quantification; mITT; modified intention-to-treat; P/R; peginterferon alfa and ribavirin; RAV; resistance-associated variants; RVR; rapid virologic respon
Allergies in high-risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study
Keywords: اصلاح قصد درمان; Birth cohort; double-blind randomized trial; nutritional intervention; cow's milk protein hydrolysate infant formulas; long-term allergy prevention; AD; Atopic eczema/dermatitis; AM; Allergic manifestation; aRR; Adjusted relative risk; CMF; Standard cow's
A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome
Keywords: اصلاح قصد درمان; HRS; hepatorenal syndrome; MELD; Model for End-Stage Liver Disease; MITT; modified intention-to-treat; SCr; serum creatinine;